Key result
A CRISPR/Cas9 and Cre-Lox system successfully deleted TK and US4 genes and inserted the Newcastle disease virus F gene into the ILTV genome without adversely affecting viral replication.
Why the study?
Conventional recombination methods to engineer gene-deletion ILTV vaccine vectors are tedious, time-demanding, and error-prone.
The NHEJ-CRISPR/Cas9 and Cre-Lox system offers a novel tool to generate multivalent vaccine vectors using ILTV for poultry pathogens.
May enable multivalent ILTV vaccine vectors for poultry; leaves open in vivo efficacy and safety validation.
Infectious laryngotracheitis virus (ILTV) is a promising vaccine vector due to its heterologous gene accommodation capabilities, low pathogenicity, and potential to induce cellular and humoral arms of immunity. Owing to these characteristics, different gene-deletion versions of ILTVs have been successfully deployed as a vector platform for the development of recombinant vaccines against multiple avian viruses using conventional recombination methods, which are tedious, time-demanding, and error-prone. Here, we applied a versatile, and customisable clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 accompanied with Cre–Lox system to simultaneously delete virulence factors and to insert foreign genes in the ILTV genome. Using this pipeline, we successfully deleted thymidine kinase (TK) and unique short 4 (US4) genes and inserted fusion (F) gene of the Newcastle disease virus without adversely affecting ILTV replication and expression of the F protein. Taken together, the proposed approach offers novel tools to attenuate (by deletion of virulence factor) and to generate multivalent (by insertion of heterologous genes) vaccine vectors to protect chickens against pathogens of poultry and public health importance.
No takes yet. Share an insight, caveat, or question.
Atasoy et al. (2019) studied Infectious laryngotracheitis virus (ILTV) vaccine vector development. CRISPR/Cas9 accompanied with Cre-Lox system was evaluated on Deletion of TK and US4 genes and insertion of F gene of Newcastle disease virus. A CRISPR/Cas9 and Cre-Lox system successfully deleted TK and US4 genes and inserted the Newcastle disease virus F gene into the ILTV genome without adversely affecting viral replication.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: